Top

Published in:

01-03-2018 | Original Article

Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience

Authors: Riccardo Casadei, Claudio Ricci, Giovanni Taffurelli, Carlo Alberto Pacilio, Marina Migliori, Francesco Minni

Published in: Updates in Surgery | Issue 1/2018

Abstract

The objective of the study was to evaluate the Fukuoka guidelines in indicating the proper management for recognising the risk factors of malignancy. Data of patients with branch duct intraductal papillary mucinous neoplasms who underwent pancreatic resection or surveillance according to the Fukuoka risk parameters were collected in a prospective database. The clinical outcome (development of pancreatic cancer, overall and disease-specific survival) and pathological results were evaluated in all patients and in resected cases, respectively. The data of 197 patients were collected: 23 primarily resected and 174 primarily followed. Of the latter, 16 were secondarily resected. Among the patients resected, 21 (53.9%) showed diagnosis of in situ or invasive carcinoma and only contrast-enhancing mural nodules were significantly related to malignancy (P = 0.002), with a DOR of 3.3 and an LH+ of 2.2. Development of pancreatic cancer was shown in ten (5.7%) of the patients primarily followed. The overall survival and disease-specific survival were similar between patients primarily followed and primarily resected. It seems reasonable to suggest that a branch duct intraductal papillary mucinous neoplasm should be treated as a benign and indolent disease that is rarely malignant. Enhancing mural nodules represent the best indicator for surgery.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239(6):788–797CrossRefPubMedPubMedCentral

Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N et al (2010) Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 251(3):470–476CrossRefPubMedPubMedCentral

Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12(3):183–197CrossRefPubMed

Anand N, Sampath K, Wu BU (2013) Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol 11:913–921CrossRefPubMed

Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG et al (2014) Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 259(1):72–81CrossRefPubMed

Ricci C, Casadei R, Taffurelli G, Zani E, Pagano N, Pacilio CA, Ingaldi C, Bogoni S, Santini D, Migliori M, Di Marco M, Serra C, Calculli L, De Giorgio R, Minni F (2016) Risk factors for malignancy of branch-duct intraductal papillary mucinous neoplasms. A critical evaluation of the fukuoka guidelines with a systematic review and meta-analysis. Pancreas 45:1243–1254CrossRefPubMed

Pelaez-Luna M, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB (2007) Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 102:1759–1764CrossRefPubMed

Ohtsuka T, Kono H, Nagayoshi Y, Mori Y, Tsutsumi K, Sadakari Y, Takahata S, Morimatsu K, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M (2012) An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 151:76–83CrossRefPubMed

Seo N, Byun JH, Kim JH, Kim HJ, Lee SS, Song KB et al (2016) Validation of the 2012 International Consensus Guidelines using computed tomography and magnetic resonance imaging branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 263:557–564CrossRefPubMed

10.

Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D et al (2013) Branch duct intraductal papillary mucinous neoplasms. Does cyst size change the tip of the scale? A critical analysis of the revised International Consensus Guidelines in a large single-Institutional series. Ann Surg 258:466–475CrossRefPubMed

11.

Fritz S, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O et al (2012) Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 256(2):313–320CrossRefPubMed

12.

Roch AM, DeWitt JM, Al-Haddad MA, Schmidt CM, Ceppa EP, House MG et al (2014) Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. J Am Coll Surg 219(1):122–129CrossRefPubMed

13.

Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28:977–987CrossRefPubMed

14.

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M et al (2006) International Consensus Guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32CrossRefPubMed

15.

Vege SS, Ziring B, Jain R, Moayyedi P, The Clinical Guidelines Committee (2015) American Gastroenterological Association Institute Guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 148:819–822CrossRefPubMed

16.

Sugiyama M, Atomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691CrossRefPubMedPubMedCentral

17.

Taouli B, Vilgrain V, Vullierme MP, Terris B, Denys A, Sauvanet A et al (2000) Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology 217:757–764CrossRefPubMed

18.

Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF (2006) Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations—correlation with MRCP. Radiology 238:560–569CrossRefPubMed

19.

Longnecker DS, Adler G, Hruban RH (2000) Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SRAL (ed) World Health Organization classification of tumors pathology and genetics of tumors of the digestive system: lyon. IARC Press, France, pp 237–241

20.

Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J (2002) Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324(7338):669–671CrossRefPubMedPubMedCentral

21.

Levy P, Jouannaud V, O’Toole D, Couvelard A, Vullierme MP, Palazzo L et al (2006) Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 4:460–468CrossRefPubMed

22.

Nagata N, Kawazoe A, Mishima S, Wada T, Shimbo T, Sekine K et al (2016) Development of pancreatic cancer, disease-specific mortality and all-cause mortality in patients nonresected IPMNs: a long-term cohort study. Radiology 278:125–134CrossRefPubMed

23.

Crippa S, Capurso G, Cammà C, Delle Fave G, Fernandez-del Castillo C, Falconi M (2016) Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: a systematic review and meta-analysis. Dig Liv Dis 48:473–479CrossRef

Title: Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience
Authors: Riccardo Casadei
Claudio Ricci
Giovanni Taffurelli
Carlo Alberto Pacilio
Marina Migliori
Francesco Minni
Publication date: 01-03-2018
Publisher: Springer Milan
Published in: Updates in Surgery / Issue 1/2018
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-017-0471-7

At a glance: The STEP trials

Springer Medicine

Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection

Modified Finney enteroplasty: a bowel sparing damage control stapled technique for penetrating jejunal and ileal injuries

Prognostic risk factors for conversion in laparoscopic cholecystectomy

Laparoscopic pancreatic resections in two medium-sized medical centres

Frailty and emergency surgery in the elderly: protocol of a prospective, multicenter study in Italy for evaluating perioperative outcome (The FRAILESEL Study)

Face and content validity of Xperience Team Trainer: bed-side assistant training simulator for robotic surgery